The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(3-(7-(2-methoxy-4-(4-methylpiperazin-1-yl)phenylamino)-4,4-dimethyl-2-oxo-2,4-dihydro-1H-pyrimido[4,5-d][1,3]oxazin-1-yl)phenyl)acrylamide ID: ALA4869608
PubChem CID: 141489873
Max Phase: Preclinical
Molecular Formula: C29H33N7O4
Molecular Weight: 543.63
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: C=CC(=O)Nc1cccc(N2C(=O)OC(C)(C)c3cnc(Nc4ccc(N5CCN(C)CC5)cc4OC)nc32)c1
Standard InChI: InChI=1S/C29H33N7O4/c1-6-25(37)31-19-8-7-9-21(16-19)36-26-22(29(2,3)40-28(36)38)18-30-27(33-26)32-23-11-10-20(17-24(23)39-5)35-14-12-34(4)13-15-35/h6-11,16-18H,1,12-15H2,2-5H3,(H,31,37)(H,30,32,33)
Standard InChI Key: DOHVJXWGWXRONK-UHFFFAOYSA-N
Molfile:
RDKit 2D
40 44 0 0 0 0 0 0 0 0999 V2000
4.4107 -0.4832 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8273 -1.1995 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2395 -0.4807 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6892 -1.6285 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.6880 -2.4555 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4026 -2.8682 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.4008 -1.2158 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1159 -1.6249 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1193 -2.4576 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8382 -2.8687 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.5583 -2.4518 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5548 -1.6190 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.8422 -3.6900 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1275 -4.1037 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1294 -4.9275 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8452 -5.3388 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5607 -4.9201 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5552 -4.0975 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9735 -2.8673 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.9728 -3.6920 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2603 -4.1058 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2593 -4.9298 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9737 -5.3434 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6906 -4.9272 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6881 -4.1047 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9741 -6.1681 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.2621 -6.5776 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2605 -7.3987 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9731 -7.8145 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.6889 -7.4030 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6921 -6.5757 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2736 -2.8621 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.2774 -5.3280 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.2825 -6.1527 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9994 -6.5605 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5710 -6.5694 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.0045 -7.3852 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9705 -8.6391 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.5459 -3.6939 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.5453 -2.8693 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
4 5 2 0
5 6 1 0
6 9 2 0
8 7 2 0
7 4 1 0
8 9 1 0
8 2 1 0
9 10 1 0
10 11 1 0
11 12 1 0
12 2 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 13 1 0
10 13 1 0
5 19 1 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 20 1 0
23 26 1 0
26 27 1 0
26 31 1 0
27 28 1 0
28 29 1 0
29 30 1 0
30 31 1 0
11 32 2 0
17 33 1 0
33 34 1 0
34 35 1 0
34 36 2 0
35 37 2 0
29 38 1 0
21 39 1 0
39 40 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 543.63Molecular Weight (Monoisotopic): 543.2594AlogP: 4.63#Rotatable Bonds: 7Polar Surface Area: 112.16Molecular Species: NEUTRALHBA: 9HBD: 2#RO5 Violations: 1HBA (Lipinski): 11HBD (Lipinski): 2#RO5 Violations (Lipinski): 2CX Acidic pKa: 13.62CX Basic pKa: 7.84CX LogP: 4.38CX LogD: 3.80Aromatic Rings: 3Heavy Atoms: 40QED Weighted: 0.41Np Likeness Score: -1.06
References 1. Yuan Y, Xu J, Jiang L, Yu K, Ge Y, Li M, He H, Niu Q, Shi X, Fan L, Chen Z, Zhao Z, Li S, Xu Y, Wang Z, Li H.. (2021) Discovery, Optimization, and Structure-Activity Relationship Study of Novel and Potent RSK4 Inhibitors as Promising Agents for the Treatment of Esophageal Squamous Cell Carcinoma., 64 (18.0): [PMID:34496560 ] [10.1021/acs.jmedchem.1c00969 ]